DA

Davide Arcidiacono

Chief Executive Officer

Angiodroid

Milan, Lombardy


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Angiodroid
Industry
medical devices
Employees
46.0
Seniority
C suite
Annual Revenue
7500000.0
Total Funding
9005830.0
Latest Funding
Series A

Technologies

Gmail Google Apps CloudFlare Hosting Hubspot Linkedin Widget Google Tag Manager Bootstrap Framework Facebook Widget Facebook Login (Connect) Linkedin Login JQuery 2.1.1 Mobile Friendly AI

Keywords

medical device medical equipment healthcare interventional radiology interventional cardiology vascular surgery peripheral angiography co2 angiography angiography vascular procedures medical equipment manufacturing co2 injector carbon dioxide angiography automated co2 injection contrast medium renal function preservation safe angiographic procedures iodine allergy alternatives patient safety precision control biocompatible contrast agent image quality enhancement medical imaging reduced x-ray exposure efficient workflow single use adaptor disposable medical devices emergency vascular procedures angiopulse technology medical device innovation non-toxic contrast options customizable parameters synchronization with x-ray systems patient comfort contrast-induced nephropathy prevention ultra-low viscosity automated contrast delivery pressure control system advanced software integration clinical applications efficient patient examinations reduced hospitalization real-time monitoring risk management in procedures non-invasive imaging techniques easy-to-use interface remote control operation surgical precision inspection system improved diagnostic accuracy renal artery imaging treatment planning imaging technology advancement surgical outcomes improvement hospital & health care health care health wellness & fitness medical devices

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans